Examkin

Soru

Zorluk: ZorMedical History Evaluation

A 29-year-old woman is evaluated in the ambulatory care clinic for a 3-month history of missed menstrual periods and a bilateral milky breast discharge. She reports feeling generally fatigued but explicitly denies headaches, visual field deficits, or cold intolerance. Her medical history includes a poorly characterized bipolar mood disorder and refractory gastroesophageal reflux disease. Her current medications include a mood stabilizer, a proton pump inhibitor, and a new medication prescribed two months ago at an urgent care clinic for persistent postprandial nausea and bloating. Physical examination reveals normal visual fields to confrontation and bilateral expressible galactorrhea. A urine pregnancy test is negative. Laboratory studies show a normal serum thyroid-stimulating hormone (TSH) level and a markedly elevated serum prolactin level of 92 ng/mL (normal: <25 ng/mL). Which of the following historical inquiries are MOST critical to identify the underlying etiology of this patient's current laboratory abnormalities? (Select all that apply)

  1. Identity of the specific agent prescribed at the urgent care clinic for her nauseaCevap
  2. Pharmacological classification of the medication utilized to manage her mood disorderCevap
  3. C
    Detailed family history regarding the onset of menopause or primary ovarian insufficiency
  4. D
    Recent dosage adjustments or prolonged use of her proton pump inhibitor therapy
  5. E
    Dietary history focusing on excessive iodine ingestion or over-the-counter kelp supplements

Cevap

Determining the precise psychotropic medication managing her mood disorder and the specific anti-emetic prescribed for her nausea, as both classes may include dopamine D2 receptor antagonists.
The correct inquiries focus on identifying medications that act as dopamine D2 receptor antagonists. Dopamine, secreted by the hypothalamus, tonically inhibits prolactin release from anterior pituitary lactotrophs. Disruption of this tuberoinfundibular pathway via D2 receptor blockade leads to hyperprolactinemia, which manifests clinically as galactorrhea and suppression of the hypothalamic-pituitary-ovarian axis (amenorrhea). The patient's history includes treatment for a mood disorder and recent therapy for nausea. First- and second-generation antipsychotics (often used in bipolar disorder) and prokinetic agents like metoclopramide (used for nausea and gastroparesis) are classic dopamine antagonists. Determining exactly which agents she is taking is the most critical step in evaluating her presentation.

Adım Adım Çözüm

1
Analyze the patient's presenting symptoms and initial laboratory findings.
The patient exhibits secondary amenorrhea, galactorrhea, and an elevated prolactin level, with a normal TSH and a negative pregnancy test.
Establishing the primary pathophysiologic derangement (hyperprolactinemia) after ruling out physiologic causes is required to guide further investigation.
2
Identify the primary mechanism regulating prolactin secretion.
Prolactin secretion from the anterior pituitary lactotrophs is tonically inhibited by dopamine released from the hypothalamus.
Understanding the tuberoinfundibular dopamine pathway is necessary to identify potential disruptors.
3
Evaluate the medical history for potential iatrogenic causes of dopamine antagonism.
The patient takes an unspecified medication for a bipolar mood disorder and a newly prescribed medication for nausea and bloating.
Many psychotropic drugs (e.g., typical and atypical antipsychotics) and gastrointestinal prokinetics (e.g., metoclopramide) are potent dopamine D2 receptor antagonists.
4
Select the historical inquiries that will confirm the etiology.
Clarifying the exact identities and classes of these two medications is the most critical next step.
Definitively linking the hyperprolactinemia to a specific pharmacological agent prevents unnecessary imaging or invasive diagnostic testing.

Anahtar Kavram

Pharmacological history evaluation in patients with hyperprolactinemia, focusing on dopamine D2 receptor antagonists.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Medical History Evaluation

Bu konudan daha fazla soru